Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
18.56
0.00 (0.00%)
At close: Oct 24, 2025, 4:00 PM EDT
18.55
-0.01 (-0.05%)
After-hours: Oct 24, 2025, 7:48 PM EDT
Avadel Pharmaceuticals Employees
Avadel Pharmaceuticals had 188 employees as of December 31, 2024. The number of employees increased by 34 or 22.08% compared to the previous year.
Employees
188
Change (1Y)
34
Growth (1Y)
22.08%
Revenue / Employee
$1,175,931
Profits / Employee
-$15,548
Market Cap
1.81B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188 | 34 | 22.08% |
| Dec 31, 2023 | 154 | 113 | 275.61% |
| Dec 31, 2022 | 41 | -25 | -37.88% |
| Dec 31, 2021 | 66 | 34 | 106.25% |
| Dec 31, 2020 | 32 | -18 | -36.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AVDL News
- 2 days ago - Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL - Business Wire
- 2 days ago - Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz - Benzinga
- 3 days ago - Alkermes to acquire Avadel for up to $2.1 billion - Reuters
- 3 days ago - Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc - PRNewsWire
- 3 days ago - Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement - GlobeNewsWire
- 11 days ago - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Avadel: Mispriced Leader In Once-Nightly Sleep Therapies - Seeking Alpha
- 5 weeks ago - Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding - GlobeNewsWire